Browsing: pill

A daily weight-loss pill made by the drug firm behind the Mounjaro jab has been approved for use in the UK – the first country in Europe to do so

Eli Lilly’s Foundayo (orforglipron) has secured UK regulatory approval for weight management and type 2 diabetes, making the UK the first European country to authorise the once-daily GLP-1 tablet

A new oral approach to GLP-1 treatment helped adults with obesity or overweight lose as much as 12 percent of their body weight over 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine

The UK has become the first country in Europe to approve a new once-a-day pill to aid weight loss and treat type 2 diabetes

There are currently over 1.2 million people in the United States who have HIV, 40 percent of them (489,200) being Black, according to KFF. For many individuals living with HIV, the requirement to take medication every day is something they have to do for the rest of their lives. Even though current antiretroviral treatments have…

When the FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025 (with the launch following in early January 2026), the response was immediate. Patients who had spent months dreading their weekly injections suddenly had a new question for their doctors, and doctors suddenly had a much harder question…

Will collagen make you look younger? Could magnesium help you sleep better? Or are the benefits overstated? A dietitian reveals which are worth taking

July 20, 2026 ByJulie Corliss, Executive Editor, Harvard Heart Letter

Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of Wegovy (semaglutide 25 mg) for adults with obesity and at least one weight-related comorbidity. The approval expands the company’s obesity franchise across Europe, making Wegovy the first GLP-1 tablet approved for weight management in the EU and…

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below